BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cariprazine long-acting injection (Mapi Pharma) readouts · As
 setMemo
X-WR-CALDESC:Upcoming readouts of Cariprazine long-acting injection (Mapi P
 harma)\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07185815-9227@assetmemo.bio
DTSTAMP:20261121T005950Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Cariprazine long-acting injection (Mapi Pharma): Phase 1/2 readout 
 est. (NCT07185815)
DESCRIPTION:Cariprazine long-acting injection (Mapi Pharma)\, phase 1/2\, S
 chizophrenia.\nStudy: Pharmacokinetics\, Safety\, Tolerability and Efficac
 y of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depo
 t) in Subjects Eligible for Treatment With Oral Cariprazine\nEstimated pri
 mary completion: 31 December 2026. This is a ClinicalTrials.gov estimate\,
  not a confirmed readout date\, and it can move.\nDrug page: https://asset
 memo.bio/drug/cariprazine-long-acting-injection-mapi-pharma#upcoming-event
 s\nRegistry record: https://clinicaltrials.gov/study/NCT07185815
URL:https://assetmemo.bio/drug/cariprazine-long-acting-injection-mapi-pharm
 a#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
